Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Lauer

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Molecular Therapy Oncolytics|April 28, 2016
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?Benjamin Ruf, Ulrich M Lauer
Future Oncology (London, England)|July 12, 2022
Oncolytic viruses: challenges and considerations in an evolving clinical landscapeUlrich M Lauer, Julia Beil
Oncolytic Virotherapy|August 12, 2016
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapyEike Binz, Ulrich M Lauer
Oncogene|March 28, 2025
Deciphering permissivity of human tumor ecosystems to oncolytic virusesBenjamin Schoeps, Ulrich M Lauer, Knut Elbers
Oncolytic Virotherapy|September 21, 2018
Three-dimensional tumor cell cultures employed in virotherapy researchLinus D Kloker, Can Yurttas, Ulrich M Lauer
Methods in Molecular Biology (Clifton, N.J.)|November 8, 2011
Preclinical testing of virotherapeutics for primary and secondary tumors of the liverMartina Zimmermann, Timo Weiland, Michael Bitzer, et al.
Gynecologic Oncology|July 19, 2011
Oncolytic virotherapy of breast cancerAndreas D Hartkopf, Tanja Fehm, Diethelm Wallwiener, et al.
Expert Opinion on Biological Therapy|August 6, 2009
Emerging gene-directed anti-tumor strategies against human hepatoblastomaSteven W Warmann, Jörg Fuchs, Michael Bitzer, et al.
The Journal of Gene Medicine|June 26, 2003
Sendai virus vectors as an emerging negative-strand RNA viral vector systemMichael Bitzer, Sorin Armeanu, Ulrich M Lauer, et al.
Frontiers in Oncology|January 10, 2022
Clinical Trials of Oncolytic Viruses in Breast CancerMary E Carter, André Koch, Ulrich M Lauer, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Molecular Therapy Oncolytics|April 28, 2016
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?Benjamin Ruf, Ulrich M Lauer
Future Oncology (London, England)|July 12, 2022
Oncolytic viruses: challenges and considerations in an evolving clinical landscapeUlrich M Lauer, Julia Beil
Oncolytic Virotherapy|August 12, 2016
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapyEike Binz, Ulrich M Lauer
Oncogene|March 28, 2025
Deciphering permissivity of human tumor ecosystems to oncolytic virusesBenjamin Schoeps, Ulrich M Lauer, Knut Elbers
Oncolytic Virotherapy|September 21, 2018
Three-dimensional tumor cell cultures employed in virotherapy researchLinus D Kloker, Can Yurttas, Ulrich M Lauer
Methods in Molecular Biology (Clifton, N.J.)|November 8, 2011
Preclinical testing of virotherapeutics for primary and secondary tumors of the liverMartina Zimmermann, Timo Weiland, Michael Bitzer, et al.
Gynecologic Oncology|July 19, 2011
Oncolytic virotherapy of breast cancerAndreas D Hartkopf, Tanja Fehm, Diethelm Wallwiener, et al.
Expert Opinion on Biological Therapy|August 6, 2009
Emerging gene-directed anti-tumor strategies against human hepatoblastomaSteven W Warmann, Jörg Fuchs, Michael Bitzer, et al.
The Journal of Gene Medicine|June 26, 2003
Sendai virus vectors as an emerging negative-strand RNA viral vector systemMichael Bitzer, Sorin Armeanu, Ulrich M Lauer, et al.
Frontiers in Oncology|January 10, 2022
Clinical Trials of Oncolytic Viruses in Breast CancerMary E Carter, André Koch, Ulrich M Lauer, et al.
Pageof 15